Benitec Biopharma
BNTC | NASDAQ
$8.54
-$0.50 (-5.53%)
At close: Nov 16, 2026, 4:00 PM ET
$8.54
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
Benitec Biopharma Company Profile
Company profile explainedCompany Profile
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Key Executives
| Name | Position |
|---|---|
| Jerel A. Banks | Executive Chairman & Chief Executive Officer |
| Sophie Mukadam | Chief Operating Officer |
| Claudia Kloth | Senior Vice President of Manufacturing |
| Megan Joan Boston | CFO & Secretary |
| Michael Graham | Head of Discovery & Founding Scientist |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 8-K | Current Report |
| Oct 20, 2026 | DEFA14A | Filing |
| Oct 20, 2026 | DEF 14A | Filing |
| Oct 05, 2026 | 8-K | Current Report |
| Sep 30, 2026 | 8-K | Current Report |
| Sep 24, 2026 | 8-K | Current Report |
| Sep 21, 2026 | EFFECT | Filing |
| Sep 14, 2026 | S-3 | Filing |
| Sep 14, 2026 | 10-K | Annual Report |
| Sep 14, 2026 | 8-K | Current Report |
Benitec Biopharma
| Country | United States |
| IPO Date | Jun 24, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 24 |
| CEO | Jerel A. Banks |
Contact Details
3940 Trust Way Hayward,
California 94545 United States
Stock Details
| Ticker Symbol | BNTC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001808898 |
| CUSIP Number | 08205P209 |
| ISIN Number | US08205P2092 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove BNTC